RGS10 and ovarian carcinoma: While total levels of histone H3 are similar at both RGS10 and GAPDH promoters in chemosensitive and chemoresistant cells (Fig. 1A), levels of acetylated histone H3 are significantly lower at RGS10 promoters in the chemoresistant C13 ovarian cancer cells as compared to chemosensitive OV2008 cells (Fig. 1B).